Navigation Links
PAREXEL International to Present at Robert W. Baird's 2008 Growth Stock Conference
Date:5/12/2008

BOSTON, May 12 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: PRXL) announced today it will be presenting at the Robert W. Baird 2008 Growth Stock Conference in Chicago, Illinois. James Winschel, Senior Vice President and Chief Financial Officer will be making a formal presentation on PAREXEL at 10:05 a.m. EDT on Thursday, May 15, 2008.

A live webcast of this presentation will be available through the "Investor Relations Webcasts" section of PAREXEL's web site at http://www.PAREXEL.com and a replay of the presentation will be available until August 15, 2008.

About the Company

PAREXEL International Corporation is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, medical communications and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 63 locations throughout 52 countries around the world, and has over 7,680 employees. For more information about PAREXEL International visit http://www.PAREXEL.com.

PAREXEL is a registered
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. PAREXEL International to Present at Bank of America 2008 Smid Cap Conference
2. International study strengthens case for daily calcium pill
3. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
4. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
5. LCA Hails International Investigators Studying Lung Cancer
6. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
7. PRA International Adds Dr. Susan Stansfield as Executive Vice President
8. Medical Services International Maintains Pace in Second Quarter
9. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
10. International Gateway Insurance Brokers Partners With MEDILINQ
11. Tulane University to receive $14M for international HIV/AIDS program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2008)...alth-related Questions for Tonight,s,Presidential ...- WebMD, the leading source of,health information,...ial,candidates, proposed health care policies, loc...t the candidates, stance on health insurance, medi... public health issues., The in-depth coverage is ...
(Date:10/7/2008)...PRNewswire-USNewswire/ -- The Ohio Nurses,Associat...ced today its,final round of endorsed candidates f...o Senate:, SD 26 Karen Gillmor (R) Tiffin, Ohio ...(R) Grove City;, HD 28 Connie Pillich (D) Cincinn...These ONA-endorsed candidates for the Ohio General...
(Date:10/7/2008)...wswire-USNewswire/ -- Kristi Yamaguchi, Olympic,Go... the Stars, has been,named chairperson for the 200...gn in an effort to help raise funds in support of ...e and promote lung health., The American Lung Ass...o conquer Tuberculosis. Today, the Lung Associatio...
(Date:10/7/2008)...ar to more expensive whole-leg color ultrasound, ...lthDay News) -- An older, simpler test to look for...osis, or DVT -- is as effective as a newer, more e...searchers found that 2-point ultrasonography of th...trasound -- was as good at detecting DVT as the ne...
Breaking Medicine News(10 mins):Health News:WebMD Highlights Presidential Candidates' Views on Health Care 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 3Health News:Kristi Yamaguchi Chairs American Lung Association Christmas Seals Campaign 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 3
....1 lakh chickens in 354 villages in Jalgaon distri...d people that there was no cause for panic.// Dist...s had been identified as being within a radius of ...Animal Diseases Laboratory in Bhopal. This third ...
...some people may be due to their inability of the b... disorder (ASD), it is characterised by varying de...l interaction and restricted, repetitive and stere...ur. It had been thought that lack of social skill...
... to the fumes of solvents used in house renovation...and lacquers//, could give rise to allergies in yo...al medical specialist at Germany's environmental a...novation work to their husbands or hired professio...
... people in North Shropshire and Wales and funded b...r// drug Herceptin, free to the Welsh breast cance... at ?47,000, will have to be borne by the other ca... With effect from February, all Welsh local Healt...
Other Medicine News:
(Date:10/7/2008)...al abstracts highlighting CIMZIA,s long-term benef...e patients presented at American College,of Gastro...e-FirstCall/ -- Data from two studies,presented th...terology,(ACG) Annual Meeting demonstrate that CIM...nti-TNF alpha (Tumor Necrosis Factor alpha) - prov...
(Date:10/7/2008)...d 15 Patient Cohort Enrolled in Stage A of Trial A...With Carboplatin and Paclitaxel -, TUSTIN, Calif....aceuticals, Inc. (Nasdaq: PPHM ), a clinical stag...antibodies for the treatment of cancer and,hepatit...t has completed,enrollment in the first stage of a...
(Date:10/6/2008)... and CHIPPENHAM, England, October 7 /PRNewswire-Fi...Mothers Index: 4565) and Vectura,Group plc ("Vectu...tudies,evaluating the efficacy, safety and tolerab...f the European Respiratory Society (ERS) in Berlin...ronium bromide), a novel,inhaled long-acting musca...
(Date:10/6/2008)...N, Oct. 6 /PRNewswire-USNewswire/ -- "A return to ...e development is without scientific,justification,...al,Alternatives to Laboratory Animals (ATLA). "An ...ine Research" concludes that vaccine responses in,...ans, and that claims of,chimpanzees, critical role...
Breaking Medicine Technology:CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 2CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 3CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 4CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 5CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 6CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 7CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 8CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 9Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 2Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 3Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 4NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 2NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 3NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 4NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 5Research Attributes Lack of HIV/AIDS Vaccine to Use of Chimpanzees 2Some Immature Brain Cells May Promote Tumors 9157 1Some Immature Brain Cells May Promote Tumors 9157 2Start Your Day the Sun Shower 28TM 29 Way 9152 1Start Your Day the Sun Shower 28TM 29 Way 9152 2Warner Chilcott to Present at the 26th Annual JPMorgan Healthcare Conference 9147 1Kiwa Fertilizers Pass Independent Tests 2483 1Kiwa Fertilizers Pass Independent Tests 2483 2Kiwa Fertilizers Pass Independent Tests 2483 3
... MALVERN, Pa.--(BUSINESS WIRE)--Apr 18, 2007 - Gem...preclinical data,from a study of its lead compound...tic leukemia (ALL). The study was discussed in an,...rican Association,for Cancer Research (AACR). Acco...ingle agent activity against ALL blast cells,and ...
...lif. and LOS ANGELES, April 18, 2007,/PRNewswire-F...ata,from two preclinical studies, one identifying ...tylase (HDAC) inhibitor and,another demonstrating ...tyrosine kinase (BTK) inhibitor compounds. The dat...ancer Research (AACR),2007 Annual Meeting being he...
Other Medicine Technology:Gemin X Presents Positive Preclinical Data of GX15-070 in Infant,ALL at AACR Meeting 2Gemin X Presents Positive Preclinical Data of GX15-070 in Infant,ALL at AACR Meeting 3Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC,Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with,Bruton's Tyrosine Kinase Inhibitors 2Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC,Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with,Bruton's Tyrosine Kinase Inhibitors 3Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC,Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with,Bruton's Tyrosine Kinase Inhibitors 4Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC,Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with,Bruton's Tyrosine Kinase Inhibitors 5
... of deflectable curve catheters designed to specif...r patients with small anatomies. Each catheter is ... the finest materials. A unique multi-step process...ion technologies results in the excellent torque a...
... of fixed curve catheters designed to specifically...ents with small anatomies. Each catheter is handcr...inest materials. A unique multi-step process that ...chnologies results in the excellent torque and fle...
4Fr, 5Fr & 6Fr diagnostic electrophysiology catheters with fixed curves.
Inquiry 4Fr, 5Fr and 6Fr diagnostic electrophysiology catheters offer simple, precise distal control with it's patented Easy-Hand steering mechanism.
Medicine Products: